Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PIMA525449

UBXN2B Monoclonal Antibody (OTI3H8)
GREENER_CHOICE

Catalog No. PIMA525449
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA525449 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA525449 Supplier Thermo Scientific Supplier No. MA525449
Add to Cart
Add to Cart

Description

UBXN2B Monoclonal Antibody (OTI3H8)

UBXN2B Monoclonal Antibody for Western Blot, Flow

TRUSTED_SUSTAINABILITY

Specifications

Antigen UBXN2B
Applications Flow Cytometry, Western Blot
Classification Monoclonal
Clone OTI3H8
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Gene UBXN2B
Gene Accession No. Q14CS0
Gene Alias NSFL1 cofactor p37; p37; p97 cofactor p37; UBX domain protein 2B; UBX domain-containing protein 2B; UBXN2B
Gene Symbols UBXN2B
Host Species Mouse
Immunogen Full length human recombinant protein of UBXN2B produced in HEK293T cell.
Purification Method Affinity Chromatography
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 137886, 477891
Target Species Human, Canine, Monkey
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.